Scholars Central

Conference abstractPublished 24 Oct 2016

Enantiospecific effects of sibutramine enantiomers on cytochrome P450 inhibition in vitro

Authors: Yu Fen Zheng, Doyun Kim, Soo Kyung Bae

Catholic University of Korea, Bucheon, Republic of Korea

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: The aim of this study was to investigate the enantioselective differences of sibutramine enantiomers in the inhibition of human CYP enzymes in vitro Methods: Using a cocktail assay, the effects of sibutramine enantiomers (R/S- form) and 4-(4-chlorobenzyl) pyridine (CBP) on the 9 CYP isoform specific marker reactions were screened in human liver microsomes. According to USFDA guidelines, phenacetin (50 Ã?¼M), coumarin (5 Ã?¼M), bupropion (50 Ã?¼M), rosiglitazone (1 Ã?¼M), tolbutamide (100 Ã?¼M), omeprazole (20 Ã?¼M), dextrophan (5 Ã?¼M), chlorzoxazone (50 Ã?¼M) and midazolam (5 Ã?¼M) were chosen as substrates of CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A, respectively. Cocktails, test compounds and NADPH regenerating system were incubated 15 min after 5 pre-incubation with human liver microsomes (HLMs) in vitro for competitive screening. The respective metabolites of the nine substrates and internal standard chlorpropamide (200 ng/mL) were measured by LC-MS/MS system. Results: CBP showed more potent inhibitory effect on CYP2B6 with IC50 values of 0.014 Ã?¼M than sibutramine enantiomers (7.07 Ã?¼M for R-form and 2.43 Ã?¼M for S-form) based on bupropion-dependent inhibition. However, CBP also potently inhibited other CYPs except CYP3A4. In addition, R-sibutramine less slightly inhibited dextromethorphan-mediated CYP2D6 activities relative to S-sibutramine, and the IC50 value was more than 50 Ã?¼M for R-sibutramine and 24.21 Ã?¼M for S-sibutramine, respectively. Conclusion: Based on these data, R-sibutramine was selective and potent inhibitor for CYP2B6 in vitro and S-sibutramine potently inhibited CYP2B6 and slight inhibited CYP2D6 when human liver microsomes were used as the enzyme source. Thus, the present findings signified that R-isomer of sibutramine is a potent stereoselective inhibitor of CYP2B6, whereas, inhibition for other CYPs was substantially negligible.

Subjects

Toxicology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Toxicology
  • SubjectToxicology
  • BylineArticles whose byline prints “Yu Fen Zheng”
  • BylineArticles whose byline prints “Doyun Kim”
  • BylineArticles whose byline prints “Soo Kyung Bae”